In RA patients, MO-MDSCs are commonly marked by CD14+HLA-DR−/low (62), whereas PMN-MDSCs are identified by CD11b+ CD33+ HLA-DRlow/− CD14− CD15+ (61). Here, CD14 is linked to rheumatoid arthritis.